01952 EVEREST MED-B
- 24.100
- +0.600+2.55%
EVEREST MED-B News
EVEREST MED-B: (1) GRANT OF OPTIONS (2) GRANT OF AWARDS (3) NON-EXEMPTED CONNECTED TRANSACTIONS - PROPOSED AWARD GRANTS TO CONNECTED PERSONS
EVEREST MED-B: (1) GRANT OF OPTIONS (2) PROPOSED GRANT OF OPTIONS (3) GRANT OF AWARDS (4) NON-EXEMPTED CONNECTED TRANSACTIONS - PROPOSED AWARD GRANT TO CONNECTED PERSONS (5) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED PERFORMANCE TARGET AWARD GRANT TO CONN
EVEREST MED-B: UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION-(1) COLLABORATION AND LICENSE AGREEMENT; AND (2) SHARE ISSUANCE AGREEMENT IN RESPECT OF THE MANUFACTURE, DEVELOPMENT AND COMMERCIALIZATION OF COVID-19 VACCINES AND CERTAIN LICENSED PRODUCTS
EVEREST MED-B: (1) GRANT OF OPTIONS (2) NON-EXEMPT CONNECTED TRANSACTION -PROPOSED AWARD GRANT TO A CONNECTED PERSON (3) NON-EXEMPT CONNECTED TRANSACTION -PROPOSED PERFORMANCE TARGET AWARD GRANT TO A CONNECTED PERSON
EVEREST MED-B: (1) GRANT OF OPTIONS, (2) GRANT OF AWARDS, (3) NON-EXEMPT CONNECTED TRANSACTIONS - PROPOSED AWARD GRANT TO CONNECTED PERSONS, (4) NON-EXEMPT CONNECTED TRANSACTIONS - PROPOSED PERFORMANCE TARGET AWARD GRANT TO CONNECTED PERSONS, (5) INCREASE
EVEREST MED-B: SUPPLEMENTAL ANNOUNCEMENT UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION
EVEREST MED-B: SUPPLEMENTAL AND CLARIFICATION ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION
EVEREST MED-B: DISCLOSEABLE TRANSACTION - (1) COVID-19 VACCINES LICENSE AGREEMENT;(2) COLLABORATION AND LICENSE AGREEMENT; AND (3) SHARE ISSUANCE AGREEMENT IN RESPECT OF THE MANUFACTURE, DEVELOPMENT AND COMMERCIALIZATION OF COVID-19 VACCINES AND CERTAIN L
EVEREST MED-B: (1) GRANT OF SHARE OPTIONS, (2) GRANT OF SHARE AWARDS, (3) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED GRANT OF SHARE AWARDS TO CONNECTED PERSONS, AND (4) PROPOSED FUTURE AWARD GRANTS
EVEREST MED-B: GRANT OF SHARE OPTIONS AND SHARE AWARDS
EVEREST MED-B: GREEN APPLICATION FORM
EVEREST MED-B: GLOBAL OFFERING
Analysis
Price Target
No Data
